1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)-

1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)- Struktur
2715120-95-7
CAS-Nr.
2715120-95-7
Englisch Name:
1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)-
Synonyma:
Upadacitinib Impurity 58;Upadacitinib Impurity 16;1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)-
CBNumber:
CB710722159
Summenformel:
C32H35N5O7S
Molgewicht:
633.71
MOL-Datei:
2715120-95-7.mol

1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)- Eigenschaften

Siedepunkt:
787.0±70.0 °C(Predicted)
Dichte
1.35±0.1 g/cm3(Predicted)
pka
3.15±0.30(Predicted)

Sicherheit

1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)- Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ShenZhen H&D Pharmaceutical Technology Co., LTD
+86-0755-22677845 +86-13627253706
sale@hdimpurity.com China 2815 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 8046 55
Shenzhen Botel Biotechnology Co. Ltd. 0755-22202135 13316968096
1979313431@qq.com China 8197 58
Molcoo Chemicals Inc. 18627923403 18627753421
3001006472@qq.com China 9174 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954
tianwen.zhan@cato-chem.com China 7721 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212
2885426135@qq.com China 6789 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18102736234 18102736234
2208093734@qq.com China 6348 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 18367470722
2885785763@qq.com China 3784 58

  • 1-Pyrrolidinecarboxylic acid, 3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-, phenylmethyl ester, (3S,4S)-
  • Upadacitinib Impurity 16
  • Upadacitinib Impurity 58
  • 2715120-95-7
Copyright 2019 © ChemicalBook. All rights reserved